Skip to main content
Top
Published in: Acta Diabetologica 9/2021

01-09-2021 | Original Article

Association of estimated glomerular filtration rate from serum creatinine and cystatin C with new-onset diabetes: a nationwide cohort study in China

Authors: Zhuxian Zhang, Panpan He, Chun Zhou, Mengyi Liu, Chengzhang Liu, Huan Li, Yuanyuan Zhang, Qinqin Li, Yan Zhang, Guobao Wang, Min Liang, Xianhui Qin

Published in: Acta Diabetologica | Issue 9/2021

Login to get access

Abstract

Aims

The association between estimated glomerular filtration rate (eGFR) and the risk of diabetes remains uncertain. We aimed to examine the association between eGFR based on creatinine (eGFRcr), cystatin C (eGFRcys), or a combination of both (eGFRcr-cys) and new-onset diabetes, using data from the China Health and Retirement Longitudinal Study (CHARLS), a nationally representative cohort study.

Methods

A total of 4,775 participants with pertinent measurements and without diabetes at baseline from CHARLS were included in the final analysis. The eGFR was calculated by creatinine, cystatin C or a combination of both using the Chronic Kidney Disease Epidemiology Collaboration equations. The study outcome was new-onset diabetes, defined as physician-diagnosed diabetes or use of glucose-lowering drugs during follow-up, or fasting glucose ≥ 126 mg/dL, random glucose ≥ 200 mg/dL, or HbA1c ≥ 6.5% (48 mmol/mol) at the exit visit.

Results

The mean age of the study population was 59.6 years. The mean values for the eGFRcr, eGFRcys, and eGFRcr-cys were 92.4, 78.9 and 85.9 mL/min/1.73m2, respectively. Over 4 years of follow-up, 612 (12.8%) participants experienced diabetes. Participants with lower eGFRcr-cys (< 60 mL/min/1.73m2) had a significantly higher risk of new-onset diabetes (adjusted OR, 1.46; 95%CI: 1.02, 2.09), compared to those with eGFRcr-cys ≥ 60 mL/min/1.73m2. However, there was no significant association between eGFRcr (< 60 vs. ≥ 60 mL/min/1.73m2; adjusted OR, 1.27; 95%CI: 0.75, 2.17) or eGFRcys (adjusted OR, 1.04; 95%CI: 0.80, 1.36) and new-onset diabetes.

Conclusions

Lower eGFRcr-cys (< 60 mL/min/1.73m2), but not eGFRcr or eGFRcys, was significantly associated with an increased risk of new-onset diabetes in Chinese adults.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zheng Y, Ley SH, Hu FB (2017) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88–98CrossRef Zheng Y, Ley SH, Hu FB (2017) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88–98CrossRef
2.
go back to reference Qin X, Li J, Zhang Y, Ma W et al (2012) Prevalence and associated factors of diabetes and impaired fasting glucose in Chinese hypertensive adults aged 45 to 75 years. PLoS ONE 7:e42538CrossRef Qin X, Li J, Zhang Y, Ma W et al (2012) Prevalence and associated factors of diabetes and impaired fasting glucose in Chinese hypertensive adults aged 45 to 75 years. PLoS ONE 7:e42538CrossRef
3.
go back to reference Petrie JR, Guzik TJ, Touyz RM (2018) Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol 34:575–584CrossRef Petrie JR, Guzik TJ, Touyz RM (2018) Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol 34:575–584CrossRef
4.
go back to reference He M, Qin X, Cui Y et al (2012) Prevalence of unrecognized lower extremity peripheral arterial disease and the associated factors in Chinese hypertensive adults. Am J Cardiol 110:1692–1698CrossRef He M, Qin X, Cui Y et al (2012) Prevalence of unrecognized lower extremity peripheral arterial disease and the associated factors in Chinese hypertensive adults. Am J Cardiol 110:1692–1698CrossRef
5.
go back to reference Miller WG, Jones GRD (2018) Estimated glomerular filtration rate; Laboratory implementation and current global status. Adv Chronic Kidney D 25:7–13CrossRef Miller WG, Jones GRD (2018) Estimated glomerular filtration rate; Laboratory implementation and current global status. Adv Chronic Kidney D 25:7–13CrossRef
6.
go back to reference Hsu C, Chertow GM, Curhan GC (2002) Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 61:1567–1576CrossRef Hsu C, Chertow GM, Curhan GC (2002) Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 61:1567–1576CrossRef
7.
go back to reference Stevens LA, Schmid CH, Greene T et al (2009) Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75:652–660CrossRef Stevens LA, Schmid CH, Greene T et al (2009) Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75:652–660CrossRef
8.
go back to reference Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221–226CrossRef Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221–226CrossRef
9.
go back to reference Inker LA, Schmid CH, Tighiouart H et al (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–29CrossRef Inker LA, Schmid CH, Tighiouart H et al (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–29CrossRef
10.
go back to reference Stevens LA, Coresh J, Schmid CH et al (2008) Estimating GFR using serum cystatin c alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis 51:395–406CrossRef Stevens LA, Coresh J, Schmid CH et al (2008) Estimating GFR using serum cystatin c alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis 51:395–406CrossRef
11.
go back to reference Eriksen BO, Mathisen UD, Melsom T et al (2010) Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 78:1305–1311CrossRef Eriksen BO, Mathisen UD, Melsom T et al (2010) Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 78:1305–1311CrossRef
12.
go back to reference Koppe L, Pelletier CC, Alix PM et al (2014) Insulin resistance in chronic kidney disease: New lessons from experimental models. Nephrol Dial Transpl 29:1666–1674CrossRef Koppe L, Pelletier CC, Alix PM et al (2014) Insulin resistance in chronic kidney disease: New lessons from experimental models. Nephrol Dial Transpl 29:1666–1674CrossRef
13.
go back to reference Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z (2018) Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus. Kidney Int 93:741–752CrossRef Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z (2018) Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus. Kidney Int 93:741–752CrossRef
14.
go back to reference Pham H, Robinson-Cohen C, Biggs ML et al (2012) Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Clin J Am Soc Nephro 7:588–594CrossRef Pham H, Robinson-Cohen C, Biggs ML et al (2012) Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Clin J Am Soc Nephro 7:588–594CrossRef
15.
go back to reference Lorenzo C, Nath SD, Hanley AJG, Abboud HE, Gelfond JAL, Haffner SM (2009) Risk of type 2 diabetes among individuals with high and low glomerular filtration rates. Diabetologia 52:1290–1297CrossRef Lorenzo C, Nath SD, Hanley AJG, Abboud HE, Gelfond JAL, Haffner SM (2009) Risk of type 2 diabetes among individuals with high and low glomerular filtration rates. Diabetologia 52:1290–1297CrossRef
16.
go back to reference Zhao Y, Hu Y, Smith JP, Strauss J, Yang G (2014) Cohort profile: The china health and retirement longitudinal study (CHARLS). Int J Epidemiol 43:61–68CrossRef Zhao Y, Hu Y, Smith JP, Strauss J, Yang G (2014) Cohort profile: The china health and retirement longitudinal study (CHARLS). Int J Epidemiol 43:61–68CrossRef
17.
go back to reference Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRef Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRef
18.
go back to reference Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K (2012) Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med 156:785–795CrossRef Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K (2012) Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med 156:785–795CrossRef
19.
go back to reference Nerpin E, Riserus U, Ingelsson E et al (2008) Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a Community-Based cohort. Diabetes Care 31:1550–1555CrossRef Nerpin E, Riserus U, Ingelsson E et al (2008) Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a Community-Based cohort. Diabetes Care 31:1550–1555CrossRef
20.
go back to reference Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T (2005) Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45:275–280CrossRef Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T (2005) Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45:275–280CrossRef
21.
go back to reference Spoto B, Pisano A, Zoccali C (2016) Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol-Renal 311:F1087–F1108CrossRef Spoto B, Pisano A, Zoccali C (2016) Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol-Renal 311:F1087–F1108CrossRef
22.
go back to reference Dogra G, Irish A, Chan D, Watts G (2006) Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis 48:926–934CrossRef Dogra G, Irish A, Chan D, Watts G (2006) Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis 48:926–934CrossRef
23.
go back to reference Meigs JB, Hu FB, Rifai N, Manson JE (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. ACC Curr J Rev 13:22CrossRef Meigs JB, Hu FB, Rifai N, Manson JE (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. ACC Curr J Rev 13:22CrossRef
24.
go back to reference Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058–1070CrossRef Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058–1070CrossRef
25.
go back to reference Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS (2002) Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int 61:186–194CrossRef Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS (2002) Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int 61:186–194CrossRef
26.
go back to reference Eid A, Bodin S, Ferrier B et al (2006) Intrinsic gluconeogenesis is enhanced in renal proximal tubules of zucker diabetic fatty rats. J Am Soc Nephrol 17:398–405CrossRef Eid A, Bodin S, Ferrier B et al (2006) Intrinsic gluconeogenesis is enhanced in renal proximal tubules of zucker diabetic fatty rats. J Am Soc Nephrol 17:398–405CrossRef
27.
go back to reference Jacob S, Henriksen EJ, Fogt DL, Dietze GJ (1996) Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 45:535–541CrossRef Jacob S, Henriksen EJ, Fogt DL, Dietze GJ (1996) Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 45:535–541CrossRef
28.
go back to reference Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME (2004) Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. Diabetes 53:989–997CrossRef Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME (2004) Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. Diabetes 53:989–997CrossRef
29.
go back to reference Yamamoto T, Nakagawa T, Suzuki H et al (2007) Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 18:1558–1565CrossRef Yamamoto T, Nakagawa T, Suzuki H et al (2007) Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 18:1558–1565CrossRef
30.
go back to reference Shlipak MG, Matsushita K, Arnlov J et al (2013) Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369:932–943CrossRef Shlipak MG, Matsushita K, Arnlov J et al (2013) Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369:932–943CrossRef
31.
go back to reference Schaeffner ES, Ebert N, Delanaye P et al (2012) Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Int Med 157:471CrossRef Schaeffner ES, Ebert N, Delanaye P et al (2012) Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Int Med 157:471CrossRef
32.
go back to reference Fan L, Inker LA, Rossert J et al (2014) Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test. Nephrol Dial Transpl 29:1195–1203CrossRef Fan L, Inker LA, Rossert J et al (2014) Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test. Nephrol Dial Transpl 29:1195–1203CrossRef
33.
go back to reference Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ (2009) For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 75:1071–1078CrossRef Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ (2009) For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 75:1071–1078CrossRef
34.
go back to reference Shardlow A, McIntyre NJ, Fraser S et al (2017) The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: a primary care cohort study. Plos Med 14:e1002400CrossRef Shardlow A, McIntyre NJ, Fraser S et al (2017) The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: a primary care cohort study. Plos Med 14:e1002400CrossRef
35.
go back to reference Glassock RJ, Rule AD (2017) Optimally predicting mortality with kidney function markers is not the same as optimally determining how kidney function predicts mortality. Nephrol Dial Transplant 32:585–587CrossRef Glassock RJ, Rule AD (2017) Optimally predicting mortality with kidney function markers is not the same as optimally determining how kidney function predicts mortality. Nephrol Dial Transplant 32:585–587CrossRef
36.
go back to reference Lee S, Park S, Ko S et al (2010) Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients. Metabolism 59:241–246CrossRef Lee S, Park S, Ko S et al (2010) Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients. Metabolism 59:241–246CrossRef
Metadata
Title
Association of estimated glomerular filtration rate from serum creatinine and cystatin C with new-onset diabetes: a nationwide cohort study in China
Authors
Zhuxian Zhang
Panpan He
Chun Zhou
Mengyi Liu
Chengzhang Liu
Huan Li
Yuanyuan Zhang
Qinqin Li
Yan Zhang
Guobao Wang
Min Liang
Xianhui Qin
Publication date
01-09-2021
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 9/2021
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-021-01719-5

Other articles of this Issue 9/2021

Acta Diabetologica 9/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.